Recurrent Intraocular Hemorrhage Secondary to Cataract Wound Neovascularization (Swan Syndrome)
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Neovascular Glaucoma: Etiology, Diagnosis and Prognosis
Seminars in Ophthalmology, 24, 113–121, 2009 Copyright C Informa Healthcare USA, Inc. ISSN: 0882-0538 print / 1744-5205 online DOI: 10.1080/08820530902800801 Neovascular Glaucoma: Etiology, Diagnosis and Prognosis Tarek A. Shazly Mark A. Latina Department of Ophthalmology, Department of Ophthalmology, Massachusetts Eye and Ear Massachusetts Eye and Ear Infirmary, Boston, MA, USA, and Infirmary, Boston, MA, USA and Department of Ophthalmology, Department of Ophthalmology, Tufts Assiut University Hospital, Assiut, University School of Medicine, Egypt Boston, MA, USA ABSTRACT Neovascular glaucoma (NVG) is a severe form of glaucoma with devastating visual outcome at- tributed to new blood vessels obstructing aqueous humor outflow, usually secondary to widespread posterior segment ischemia. Invasion of the anterior chamber by a fibrovascular membrane ini- tially obstructs aqueous outflow in an open-angle fashion and later contracts to produce secondary synechial angle-closure glaucoma. The full blown picture of NVG is characteristized by iris neovas- cularization, a closed anterior chamber angle, and extremely high intraocular pressure (IOP) with severe ocular pain and usually poor vision. Keywords: neovascular glaucoma; rubeotic glaucoma; neovascularization; retinal ischemia; vascular endothe- lial growth factor (VEGF); proliferative diabetic retinopathy; central retinal vein occlusion For personal use only. INTRODUCTION tive means of reversing well established NVG and pre- venting visual loss in the majority of cases; instead bet- The written -
Fibroblast Growth Factor-2 Drives and Maintains Progressive Corneal Neovascularization Following HSV-1 Infection
ARTICLES Fibroblast growth factor-2 drives and maintains progressive corneal neovascularization following HSV-1 infection HR Gurung1, MM Carr2, K Bryant2, AJ Chucair-Elliott2 and DJJ Carr1,2 Herpes simplex virus type 1 (HSV-1) infection of the cornea induces vascular endothelial growth factor A (VEGF-A)- dependent lymphangiogenesis that continues to develop well beyond the resolution of infection. Inflammatory leukocytes infiltrate the cornea and have been implicated to be essential for corneal neovascularization, an important clinically relevant manifestation of stromal keratitis. Here we report that cornea infiltrating leukocytes including neutrophils and T cells do not have a significant role in corneal neovascularization past virus clearance. Antibody- mediated depletion of these cells did not impact lymphatic or blood vessel genesis. Multiple pro-angiogenic factors including IL-6, angiopoietin-2, hepatocyte growth factor, fibroblast growth factor-2 (FGF-2), VEGF-A, and matrix metalloproteinase-9 were expressed within the cornea following virus clearance. A single bolus of dexamethasone at day 10 post infection (pi) resulted in suppression of blood vessel genesis and regression of lymphatic vessels at day 21 pi compared to control-treated mice. Whereas IL-6 neutralization had a modest impact on hemangiogenesis (days 14–21 pi) and lymphangiogenesis (day 21 pi) in a time-dependent fashion, neutralization of FGF-2 had a more pronounced effect on the suppression of neovascularization (blood and lymphatic vessels) in a time-dependent, leukocyte- independent manner. Furthermore, FGF-2 neutralization suppressed the expression of all pro-angiogenic factors measured and preserved visual acuity. INTRODUCTION corneal neovascularization is topical administration of steroid The cornea is an immune privileged tissue and its transparency is or non-steroid anti-inflammatory drugs, unwarranted side critical for optimal visual acuity. -
Retinal Disease Nick Cassotis, DVM, Dipl
Thank you to our sponsor! Retinal disease Nick Cassotis, DVM, Dipl. ACVO Evaluation of the ocular fundus and establishing a diagnosis of retinal disease are complicated by good visualization of the posterior portion of the eye. The two methods for evaluation of the retina and optic nerve head are direct ophthalmoscopy and indirect ophthalmoscopy. Direct ophthalmoscopy creates a very magnified view of the optic nerve head and the immediate surrounding retina. This allows for excellent visualization of the optic nerve, however, is considered by most ophthalmologists to be a poor way of understanding the health and structure of the posterior ocular tissues. Indirect ophthalmoscopy is almost exclusively used by veterinary ophthalmologists for evaluation of the animal fundus. This examination skill requires very little instrumentation: either a 20 or 28 diopter lens and a light source. Pupillary dilation with tropicamide (not atropine) will facilitate easy visualization. As a beginner, you will benefit from pupillary dilation, holding the light source in your right hand close to your face, obtaining a tapetal reflection (aim from a low angle toward the tapetum) and hold the lens 3-5cm from the cornea in your outstretched left hand. You will benefit from a technician holding the patient’s eyelids open. Practice until this is a quick and easily performed technique. The lecture reviews techniques for indirect ophthalmoscopy and video indirect ophthalmoscopy in an effort to increase the use of this particular skillset in general practice. Indirect ophthalmoscopy improves visualization of the entire retina and optic nerve head. The technique will be compared to the more commonly performed and often blurry overmagnified direct ophthalmoscopy. -
Hyphema. Part I. Pathophysiologic Considerations
University of Pennsylvania ScholarlyCommons Departmental Papers (Vet) School of Veterinary Medicine 11-1-1999 Hyphema. Part I. Pathophysiologic Considerations András M. Komáromy David T. Ramsey Dennis E. Brooks Cynthia C. Ramsey Maria E. Kallberg See next page for additional authors Follow this and additional works at: https://repository.upenn.edu/vet_papers Part of the Ophthalmology Commons, and the Veterinary Medicine Commons Recommended Citation Komáromy, A. M., Ramsey, D. T., Brooks, D. E., Ramsey, C. C., Kallberg, M. E., & Andrew, S. E. (1999). Hyphema. Part I. Pathophysiologic Considerations. Compendium on Continuing Education for the Practicing Veterinarian, 21 (11), 1064-1069. Retrieved from https://repository.upenn.edu/vet_papers/51 Dr. Komáromy was affiliated with the University of Pennsylvania from 2003-2012. Part II can be found at http://repository.upenn.edu/vet_papers/52/ This paper is posted at ScholarlyCommons. https://repository.upenn.edu/vet_papers/51 For more information, please contact [email protected]. Hyphema. Part I. Pathophysiologic Considerations Abstract Hemorrhage in the anterior chamber of the eye, or hyphema, results from a breakdown of the blood-ocular barrier (BOB) and is frequently associated with inflammation of the iris, ciliary body, or retina. Hyphema can also occur by retrograde blood flow into the anterior chamber via the aqueous humor drainage pathways without BOB breakdown. Hyphema attributable to blunt or perforating ocular trauma is more common than that resulting from endogenous causes. When trauma has been eliminated as a possible cause, it is prudent to assume that every animal with hyphema has a serious systemic disease until proven otherwise. Disciplines Medicine and Health Sciences | Ophthalmology | Veterinary Medicine Comments Dr. -
Intraocular Foreign Body: Diagnostic Protocols and Treatment Strategies in Ocular Trauma Patients
Journal of Clinical Medicine Article Intraocular Foreign Body: Diagnostic Protocols and Treatment Strategies in Ocular Trauma Patients Hyun Chul Jung 1, Sang Yoon Lee 2, Chang Ki Yoon 1, Un Chul Park 1 , Jang Won Heo 3 and Eun Kyoung Lee 1,* 1 Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul 03080, Korea; [email protected] (H.C.J.); [email protected] (C.K.Y.); [email protected] (U.C.P.) 2 Department of Ophthalmology, Seoul National University Hospital Biomedical Research Institute, Seoul 03080, Korea; [email protected] 3 The One Seoul Eye Clinic, Seoul 06035, Korea; [email protected] * Correspondence: [email protected]; Tel.: +82-2-2072-2053 Abstract: Intraocular foreign bodies (IOFBs) are critical ophthalmic emergencies that require urgent diagnosis and treatment to prevent blindness or globe loss. This study aimed to examine the various clinical presentations of IOFBs, determine the prognostic factors for final visual outcomes, establish diagnostic protocols, and update treatment strategies for patients with IOFBs. We retrospectively reviewed patients with IOFBs between 2005 and 2019. The mean age of the patients was 46.7 years, and the most common mechanism of injury was hammering (32.7%). The most common location of IOFBs was the retina and choroid (57.7%), and the IOFBs were mainly metal (76.9%). Multivariate regression analysis showed that poor final visual outcomes (<20/200) were associated with posterior segment IOFBs (odds ratio (OR) = 11.556, p = 0.033) and retinal detachment (OR = 4.781, p = 0.034). Diagnosing a retained IOFB is essential for establishing the management of patients with ocular trauma. -
Observation of Optic Disc Neovascularization Using OCT
www.nature.com/scientificreports OPEN Observation of optic disc neovascularization using OCT angiography in proliferative Received: 13 December 2017 Accepted: 16 February 2018 diabetic retinopathy after Published: xx xx xxxx intravitreal conbercept injections Xiao Zhang1, Chan Wu1, Li-jia Zhou2 & Rong-ping Dai1 This study reports the short-term efcacy and safety of intravitreal conbercept injections for neovascularization at the disc (NVD) in patients with proliferative diabetic retinopathy (PDR). Conbercept is a recombinant fusion protein with a high afnity for all isoforms of vascular endothelial growth factor (VEGF)-A, placental growth factor and VEGF-B. A prospective case series study was conducted in 15 patients (15 eyes). Patients had complete ocular examinations and received a 0.5 mg intravitreal conbercept injection followed by supplemental pan-retinal photocoagulation (PRP). Optical coherence tomography angiography (OCTA) was performed before and after treatment. Before treatment, the mean NVD area was 1.05 ± 0.33 mm2, and it decreased to 0.56 ± 0.17 mm2 after an interval of 7.5 d (p = 0.000). One eye required vitrectomy during follow-up. Recurrent NVD was observed in 2 eyes, which resolved after repeated injections. The remaining 12 eyes were stable over a mean follow-up period of 8.3 months. The mean area of the NVD in 14 patients without vitrectomy was 0.22 ± 0.11 mm2 (p = 0.000) at the last visit. Intravitreal conbercept injections combined with intensive PRP are an efective and safe treatment for PDR with NVD. Quantitative information on NVD can be obtained with OCTA, which may be clinically useful in evaluating the therapeutic efect. -
Diagnosis and Management of Vitreous Hemorrhage
American Academy of Ophthalmology OCAL CLINICAL MODULES FOR OPHTHALMOLOGISTS VOLUME XVIII NUMBER 10 DECEMBER 2000 (SECTION 1 OF 3) Diagnosis and Management of Vitreous Hemorrhage Andrew W. Eller, M.D. Reviewers and Contributing Editors Editors for Retina and Vitreous: Dennis M. Marcus, M.D. Paul Sternberg, Jr., M.D. Basic and Clinical Science Course Faculty, Section 12: Harry W. Flynn, Jr., M.D. Consultants Practicing Ophthalmologists Advisory Committee Dennis M. Marcus, M.D. for Education: Edgar L. Thomas, M.D. Rick D. Isernhagen, M.D. l]~ THE fOUNDATION [liO) LIFELONG EDUCATION ~OF THE AMERICAN ACADEMY FOR THE OPHTHALMOLOGIST OF OPHTHALMOLOGY Focal Points Editorial Review Board Diagnosis and Management of Michael W Belin, M.D., Albany, NY; Editor-in-Chief; Cornea, Vitreous Hemorrhage External Disease & Refractive Surgery; Optics & Refraction • Charles Henry, M.D., Little Rock, AR; Glaucoma • Careen Yen Lowder, M.D., Ph.D., Cleveland , OH; Ocular Inflammation & INTRODUCTION Tumors • Dennis M. Marcus, M .D., Augusta, GA; Retina & Vitreous • Jeffrey A. Nerad, M.D., Iowa City, IA; Oculoplastic, PATHOGENESIS Lacrimal & Orbital Surgery • Priscilla Perry, M.D., Monroe, Neovascularization of Retina and Disc LA; Cataract Surgery; Liaison for Practicing Ophthalmologists Rupture of a Normal Retinal Vessel Advisory Committee for Education • Lyn A. Sedwick, M.D., Diseased Retinal Vessels Orlando, FL; Neuro-Ophthalmology • Kenneth W. Wright, M.D., Los Angeles, CA; Pediatric Ophthalmology & Strabismus Extension Through the Retina CLINICAL MANIFESTATIONS Focal Points Staff History Susan R. Keller, Managing Editor • Kevin Gleason and Victoria Vandenberg, Medical Editors Ocular Examination DIAGNOSTIC STUDIES Clinical Education Secretaries and Staff Thomas A. Weingeist, Ph.D., M.D., Iowa City, IA; Senior B-Scan Ultrasound Secretary • Michael A. -
Iris Rubeosis, Severe Respiratory Failure and Retinopathy of Prematurity – Case Report
View metadata, citation and similar papers at core.ac.uk brought to you by CORE +MRIOSP4SPprovided by Via Medica Journals 46%')/%>9-78='>2) neonatologia Iris rubeosis, severe respiratory failure and retinopathy of prematurity – case report Rubeoza tęczówki, ciężka niewydolność oddechowa i retinopatia wcześniaków – opis przypadku 0RQLND0RGU]HMHZVND8UV]XOD.XOLN:RMFLHFK/XELĔVNL Department of Ophthalmology, Pomeranian Medical University, Szczecin, Poland Abstract The aim: Case study reports for the first time about development of massive iris neovascular complication in co- urse of retinopathy of prematurity related to systemic and ocular ischemic syndrome due to tracheostomy-requiring extremely severe premature respiratory failure. Material and method: Premature female, 950 grams birth weight, born from 17-year-old gravida 1, at 28 weeks’ gestation by cesarean section due to premature placental abruption with threatening hemorrhages, with 1 to 5 Apgar score. The baby developed severe respiratory failure which required tracheostomy, advanced bronchopulmo- nary dysplasia treated with steroids (BPD) and respiratory distress syndrome (RDS) with failure to extubate together with secondary ocular ischemia. All the mentioned with multifactorial organs complications (NEC, leucopenia, ane- mia, pneumonia, periventricular leucomalacia, electrolyte abnormalities and metabolic acidosis) resulted in massive peripupillary iris neovascularization (NVI) in both eyes coexisting with retinopathy of prematurity (ROP) in 38 weeks’ PMA infant. Ultrasonography-B, slit-lamp and indirect fundus examinations with photography were used to document focusing ocular diagnosis. The previous retinopathy of prematurity screening examinations performed at standard intervals of time starting from four weeks of life, that is 32 weeks’ PMA continuing every two weeks did not present typical lesions seen in retinopathy, however in the second zone of retina slightly marked “plus sign” was visible. -
Rubeosis Iridis Or Neovascularization of the Iris in Diabetes
1/6/2021 Rubeosis iridis or neovascularization of the iris in diabetes (http://medicine.uiowa.edu/eye/) Search Ophthalmology and Visual Sciences (http://medicine.uiowa.edu/eye) (../../../index.htm) Rubeosis iridis or neovascularization of the iris in diabetes Contributor: Johanna Beebe (../../../bio/authors/Beebe-Dijkstal-Johanna.htm), MD and Jaclyn Haugsdal (../../../bio/authors/Haugsdal-Jaclyn.htm), MD Photographer: Cindy Montague, CRA This is a 57-year-old man with a past medical history of diabetes mellitus type 2, who presented to the ophthalmology clinic for decreased vision. His most recent hemoglobin A1c was 12.8%. Upon applanation his intraocular pressures were 11 mmHg OD and 32 mmHg OS. Both eyes had fine vessels coursing along the iris surface in an irregular path directed radially towards the angle. His anterior segment exam demonstrated tus of vessels along the pupillary margin in the le eye and fine vessel extending from the angle at 3 o'clock. There was a 1 mm layered hyphema in the le eye. On gonioscopy, he had a 35 degree angle and 360 degrees of neovascularization of the angle in both eyes. Posterior segment exam showed severe proliferative diabetic retinopathy in both eyes. Neovascularization of the iris (NVI), also known as rubeosis iridis, is when small fine, blood vessels develop on the anterior surface of the iris in response to retinal ischemia. These changes most oen develop at the pupillary border, but it is important to perform gonioscopy in order to investigate for involvement of the angle. Patients with NVI are prone to spontaneous hyphemas as these blood vessels are fragile and lend to bleeding. -
Search Strategies for Identifying Systematic Reviews in Eyes and Vision Research
Page 1 of 5 Search Strategies for Identifying Systematic Reviews in Eyes and Vision Research Page 2 of 5 PubMed Search strategies for identifying eyes and vision systematic reviews (ABNORMAL ACCOMMODATION[tiab] OR Abnormal color vision[tiab] OR ABNORMAL LACRIMATION[tiab] OR Abnormal vision[tiab] OR accommodative disorders[tiab] OR Amblyopia[tiab] OR Ametropia[tiab] OR ANISOCORIA[tiab] OR ANOPHTHALMIA[tiab] OR Anterior CHAMBER hemorrhage[tiab] OR Aphakia[tiab] OR aqueous outflow obstruction[tiab] OR Asthenopia[tiab] OR Balint's syndrome[tiab] OR Bilateral visual field constriction[tiab] OR Binocular Vision Disorder[tiab] OR BLEPHARITIS[tiab] OR BLEPHAROSPASM[tiab] OR BLINDNESS[tiab] OR blurred vision[tiab] OR CATARACT[tiab] OR Cataracts[tiab] OR Chorioretinal disorder[tiab] OR Chorioretinitis[tiab] OR Choroid Diseases[tiab] OR Choroidal[tiab] OR Choroiditis[tiab] OR CHROMATOPSIA[tiab] OR Color Blindness[tiab] OR Color Vision Defects[tiab] OR Color vision deficiency[tiab] OR Colour blindness[tiab] OR Conjunctival Diseases[tiab] OR CONJUNCTIVAL HAEMORRHAGE[tiab] OR Conjunctival Injury[tiab] OR CONJUNCTIVAL ULCERATION[tiab] OR CONJUNCTIVITIS[tiab] OR CORNEAL DEPOSITS[tiab] OR Corneal Diseases[tiab] OR Corneal Disorder[tiab] OR Corneal injuries[tiab] OR Corneal Injury[tiab] OR CORNEAL OEDEMA[tiab] OR CORNEAL OPACITY[tiab] OR CORNEAL ULCERATION[tiab] OR decreased Lacrimation[tiab] OR Decreased vision[tiab] OR defective vision[tiab] OR Delayed visual maturation[tiab] OR Difficulty seeing[tiab] OR difficulty with vision[tiab] OR Dim vision[tiab] -
NIH Public Access Author Manuscript Int Ophthalmol Clin
NIH Public Access Author Manuscript Int Ophthalmol Clin. Author manuscript; available in PMC 2012 July 1. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Int Ophthalmol Clin. 2011 ; 51(3): 27±36. doi:10.1097/IIO.0b013e31821e5960. Medical and Surgical Treatment of Neovascular Glaucoma Lisa C. Olmos, M.D., M.B.A. and Richard K. Lee, M.D., Ph.D. Bascom Palmer Eye Institute, University of Miami Miller School of Medicine Miami, FL INTRODUCTION Neovascular glaucoma (NVG) is an aggressive type of glaucoma, which often results in poor visual outcomes. Most NVG patients have severe underlying systemic and ocular pathology which causes NVG as a late presentation of their primary systemic and/or ocular disease. This makes NVG very difficult to treat. The key to adequate treatment of this devastating ocular disease is an understanding of its pathogenesis, which has recently been better elucidated. Weiss and colleagues first proposed the term “neovascular glaucoma” in 1963, when they described a severe glaucoma associated with the presence of new iris and angle vessels. (1) These patients present with elevated intraocular pressure (IOP) and neovascularization of the iris and angle, often with hyphema and other ocular findings, such as ectropion uveae (Figure 1). The myriad medical conditions resulting in NVG all lead to a final common pathway of profound retinal ischemia. This ischemia induces retinal production of vasoproliferative factors, including vascular endothelial growth factor (VEGF), which diffuse anteriorly and lead to anterior segment neovascularization of the iris (NVI) and neovascularization of the angle (NVA). -
Ocular Neovascularization: a Valuable Model System
Oncogene (2003) 22, 6537–6548 & 2003 Nature Publishing Group All rights reserved 0950-9232/03 $25.00 www.nature.com/onc Ocular neovascularization: a valuable model system Peter Anthony Campochiaro*,1 and Sean Francis Hackett1 1The Departments of Ophthalmology and Neuroscience, The Johns Hopkins University School of Medicine, Maumenee 719, 600 N. Wolfe Street, Baltimore, MD 21287-9277, USA There is no unique formula for angiogenesis. Instead there related proteins, and/or their induced expression, which is a large group of potential participating proteins that may alter the angiogenesis cascade and may even alter interact in complex ways. Depending upon the surround- the effects of particular proteins. Some proteins promote ing cell types and the relative expression levels of angiogenesis in one setting and suppress it in others. angiogenesis-related proteins,the ‘angiogenesis cascade’ Proteins depend upon other proteins for their actions can vary. Therefore,it is valuable to study and compare and lack of expression of a binding partner in a the role of proteins in several well-characterized vascular particular locale may have a profound effect on the beds. The eye provides a useful model system,because it action of a protein. contains several vascular beds sandwiched between In order to define the potential actions of a protein avascular tissue. This allows for unequivocal identification and its interactions with other proteins in angiogenesis, and quantitation of new vessels. Retina-specific promoters it is useful to study its effects in several well-character- combined with inducible promoter systems provide a ized vascular beds and in different types of angiogenesis.